Structure analysis based identification of novel anti-hiv drugs

Informazioni relative al progetto

ID dell’accordo di sovvenzione: QLK2-CT-2000-41485

Progetto chiuso

Data di avvio 20 Dicembre 2000

Data di completamento 19 Dicembre 2001

Finanziato da

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Costo totale € 29 500,00

Contributo UE € 22 125,00

Coordinato da

STRUCTURAL BIOINFORMATICS ADVANCED TECHNOLOGIES A/S
Denmark

Obiettivo

The present project combines bio informatics approaches with powerful experimental techniques for revealing protein/protein interactions and the efficiency of inhibitor binding with focus on selected HIV proteins. The project includes a novel, massive use of protein structure models for determination of the structural variability of a very large number of mutants, with the aim of developing therapeutic intervention against HIV that can cope with the substantial mutation capability of the virus.

Campo scientifico

• natural sciences › biological sciences › microbiology › virology
• natural sciences › biological sciences › biochemistry › biomolecules › proteins
• medical and health sciences › health sciences › infectious diseases › RNA viruses › HIV
• natural sciences › biological sciences › genetics › mutation

Programma(i)

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Argomento(i)

• 1.1.1.-2. - Key action Control of Infectious Diseases

Invito a presentare proposte

Data not available

Meccanismo di finanziamento

EAW - Exploratory awards

Coordinatore

STRUCTURAL BIOINFORMATICS ADVANCED TECHNOLOGIES A/S

• Contributo UE: Nessun dato
• Indirizzo: Agern Alle 3 ; 2970 HOERSHOLM ; Danimarca
• Costo totale: Nessun dato

Partecipanti (1)

HYBRIGENICS

Francia

• Contributo UE: Nessun dato
• Indirizzo: Impasse Reille 3-5 ; 75014 PARIS
• Costo totale: Nessun dato